Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa.

The findings of this epidemiologic study highlight the temporal course and severity of ototoxicity experienced by cervical cancer patients treated with cisplatin, with greater impact in HIV-positive subgroup, thus underscores the need for audiological monitoring and timely interventions in this cohort.